lemas
I wonder if the company doing the funding is allowed to buy stock before the funding takes place, owing to the fact I imagine they'll have inside information on where the company is going etc.
If not they could be buying at the moment at these cheaper levels.
I don't think they would have to show their hand until they have accumulated 5%...correct?
That would give them a nice size parcel of around 12m (5%) plus 17.4m new shares. Somewhere around 12.5%
Greyhoundtrainer with the closeness of the company finally getting to making money, unless I was short of money and had to sell it would seem stupid to me at selling now, when a month or so down the way the SP has got a very good chance of starting to head up.
It's not just a dream anymore.
Is the average price of the 5 days prior closing price or the overall trading day price....if it's closing price we'll just have to make sure it closes right every day.
VVS there was no offence taken by your remark earlier. I thought you were joking.
Regards Dabru
- Forums
- ASX - By Stock
- looking good for 2009
lemasI wonder if the company doing the funding is allowed to buy...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLT (ASX) to my watchlist
(20min delay)
|
|||||
Last
74.0¢ |
Change
0.020(2.78%) |
Mkt cap ! $129.7M |
Open | High | Low | Value | Volume |
72.0¢ | 74.0¢ | 72.0¢ | $40.16K | 54.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 71.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
74.0¢ | 5532 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.710 |
1 | 1400 | 0.690 |
1 | 7911 | 0.685 |
1 | 9000 | 0.680 |
2 | 2488 | 0.670 |
Price($) | Vol. | No. |
---|---|---|
0.740 | 5532 | 1 |
0.760 | 30000 | 1 |
0.765 | 5000 | 1 |
0.770 | 1500 | 1 |
0.775 | 5000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PLT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online